INFINITI FLU A-sH1N1

  • The INFINITI FLU A-sH1N1 is CE Marked.
  • The INFINITI FLU A-sH1N1 is designed to detect influenza A and differentiate between influenza A and influenza A subtype Swine H1N1 (2009).
  • The INFINITI FLU A-sH1N1 utilizes the FLU A-sH1N1 Intellipac, FLU A-sH1N1 Amp Mix and the FLU A-sH1N1 BioFilmChip Microarray.
  • The INFINITI FLU A-sH1N1 is automated by the INFINITI Analyzer.

Analytes Detected: 
  • Influenza                                                 
  • A-Swine H1N1 (2009)
Features: 
  • Simultaneous multiplexed determination of influenza A subtype Swine H1N1 (2009)
  • Rapid turnaround time enhances workflow efficiency
  • Load & Go automated on the INFINITI/INFINITI PLUS Analyzer.
  • Replicate determinations on a single BioFilmChip Microarray ensures quality results.

Sample Type and Volume: 
  • Uses nasopharyngeal aspirates (NPA).
  • Requires 8 ul of purified RNA/reaction
Clinical Relevance: 
  • Only 28% of hospitalizations and 17% of children with laboratory-confirmed influenza infections were diagnosed as actually having influenza.
Clinical Utility: 
  • Rapid respiratory virus diagnosis of inpatients can lead to benefits in several areas: up to 50% reduction in hospital days, 30% reduction in antibiotic use, and 20% reduction in unnecessary diagnostic tests and procedures.
  • Will allow:
    • public health labs to track multiple viruses with 1 sampling
    • monitoring of viral subtypes in the populace
    • easy integration to existing workflows
References: 
  1. K.A. Poehling, et.al., The Underrecognized Burden of Influenza in Young Children NEJM, 2006;355:31-40.
  2. CDC: Disease Surveillance
  3. Hendrickson, K. J.  2005. Cost-effective use of rapid diagnostic
    techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann 34(1) 24-31.

INFINITI FLU A-sH1N1